BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20687892)

  • 1. The role of nuclear factor-kappaB in inflammatory lung disease.
    Imanifooladi AA; Yazdani S; Nourani MR
    Inflamm Allergy Drug Targets; 2010 Jul; 9(3):197-205. PubMed ID: 20687892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy.
    Wright JG; Christman JW
    Am J Respir Med; 2003; 2(3):211-9. PubMed ID: 14720003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor-kappa B and its role in inflammatory lung disease.
    Alharbi KS; Fuloria NK; Fuloria S; Rahman SB; Al-Malki WH; Javed Shaikh MA; Thangavelu L; Singh SK; Rama Raju Allam VS; Jha NK; Chellappan DK; Dua K; Gupta G
    Chem Biol Interact; 2021 Aug; 345():109568. PubMed ID: 34181887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of NF-kappaB in immune and inflammatory responses in the gut.
    Neurath MF; Becker C; Barbulescu K
    Gut; 1998 Dec; 43(6):856-60. PubMed ID: 9824616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bronchial asthma, chronic obstructive pulmonary disease and NF-kappaB.
    Charokopos N; Apostolopoulos N; Kalapodi M; Leotsinidis M; Karamanos N; Mouzaki A
    Curr Med Chem; 2009; 16(7):867-83. PubMed ID: 19275599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear factor-κB: a key regulator in health and disease of lungs.
    Batra S; Balamayooran G; Sahoo MK
    Arch Immunol Ther Exp (Warsz); 2011 Oct; 59(5):335-51. PubMed ID: 21786215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks.
    Uwe S
    Biochem Pharmacol; 2008 Apr; 75(8):1567-79. PubMed ID: 18070616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription Factor NF-κB: An Update on Intervention Strategies.
    Panday A; Inda ME; Bagam P; Sahoo MK; Osorio D; Batra S
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(6):463-483. PubMed ID: 27236331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB regulation in the immune system.
    Li Q; Verma IM
    Nat Rev Immunol; 2002 Oct; 2(10):725-34. PubMed ID: 12360211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A20 regulation of nuclear factor-κB: perspectives for inflammatory lung disease.
    Kelly C; Shields MD; Elborn JS; Schock BC
    Am J Respir Cell Mol Biol; 2011 Jun; 44(6):743-8. PubMed ID: 21239605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease.
    Edwards MR; Bartlett NW; Clarke D; Birrell M; Belvisi M; Johnston SL
    Pharmacol Ther; 2009 Jan; 121(1):1-13. PubMed ID: 18950657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-κB cellular and molecular regulatory mechanisms and pathways: therapeutic pattern or pseudoregulation?
    Haddad JJ; Abdel-Karim NE
    Cell Immunol; 2011; 271(1):5-14. PubMed ID: 21777910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappaB as a therapeutic target in chronic inflammation: recent advances.
    Makarov SS
    Mol Med Today; 2000 Nov; 6(11):441-8. PubMed ID: 11074370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of NF-kappaB in endotoxemia-induced alterations of lung neutrophil apoptosis.
    Kupfner JG; Arcaroli JJ; Yum HK; Nadler SG; Yang KY; Abraham E
    J Immunol; 2001 Dec; 167(12):7044-51. PubMed ID: 11739525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effects of astroglial α7 nicotinic acetylcholine receptors are mediated by inhibition of the NF-κB pathway and activation of the Nrf2 pathway.
    Patel H; McIntire J; Ryan S; Dunah A; Loring R
    J Neuroinflammation; 2017 Sep; 14(1):192. PubMed ID: 28950908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The non-canonical NF-κB pathway in immunity and inflammation.
    Sun SC
    Nat Rev Immunol; 2017 Sep; 17(9):545-558. PubMed ID: 28580957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nuclear factor kappa B signaling pathway: integrating metabolism with inflammation.
    Tornatore L; Thotakura AK; Bennett J; Moretti M; Franzoso G
    Trends Cell Biol; 2012 Nov; 22(11):557-66. PubMed ID: 22995730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalin attenuates inflammation by inhibiting NF-kappaB activation in cigarette smoke induced inflammatory models.
    Lixuan Z; Jingcheng D; Wenqin Y; Jianhua H; Baojun L; Xiaotao F
    Pulm Pharmacol Ther; 2010 Oct; 23(5):411-9. PubMed ID: 20566376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear Factor-κB Activation as a Pathological Mechanism of Lipid Metabolism and Atherosclerosis.
    Yu XH; Zheng XL; Tang CK
    Adv Clin Chem; 2015; 70():1-30. PubMed ID: 26231484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NF-kappaB Signaling in Chronic Inflammatory Airway Disease.
    Schuliga M
    Biomolecules; 2015 Jun; 5(3):1266-83. PubMed ID: 26131974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.